Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome

Br J Haematol. 2011 Jul;154(1):141-3. doi: 10.1111/j.1365-2141.2010.08438.x. Epub 2011 Feb 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Hodgkin Disease / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine